Month: August 2021

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)

Written by Customer Service on August 19, 2021. Posted in Public Companies.

Collaboration to evaluate NEObody™ product candidate, ADG106, in combination with KEYTRUDA® for patients with advanced or metastatic solid and/or hematological malignancies SAN FRANCISCO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that it has entered into a third clinical trial collaboration and supply agreement with Merck (known as “MSD” outside the United States and Canada). The agreement includes an open-label, dose escalation and expansion clinical study of ADG106 in combination with Merck’s anti-PD-1 KEYTRUDA® (pembrolizumab) in advanced or metastatic solid and/or hematological malignancies (ADG106-P2001/KEYNOTE-D12). This...

Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms

Written by Customer Service on August 19, 2021. Posted in Public Companies.

TORONTO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“Silo Wellness” or the “Company”) (CSE: SILO) (OTCQB: SILFF) (FRA: 3K70), a leading global psychedelics company, today announced a $3 million national distribution agreement with Texas-based distribution and advertising company One Light Enterprises LLC. (“One Light”) for Silo Wellness’ portfolio of Marley One branded mushroom products across 47 U.S. states (the “Distribution Agreement”). Today’s announcement comes on the heels of Silo Wellness’ U.K. distribution agreement with LocoSoco Group PLC, announced earlier this month. Together with the Distribution Agreement, Silo Wellness has cemented strong routes to market in both the U.S. and the U.K. for its Marley One global mushroom brand, created in collaboration with the family of legendary musician Bob Marley. “We...

Plus Therapeutics Presents Data from Preclinical Study of Rhenium-186 Nanoliposome in Leptomeningeal Metastases and Plans for Further Evaluation with Upcoming Phase 1 Clinical Trial

Written by Customer Service on August 19, 2021. Posted in Public Companies.

Positive data to support FDA IND application for the clinical evaluation of Rhenium-186 Nanoliposome (186RNL) targeted radiotherapy for patients with leptomeningeal metastases (LM) Presentation outlines plans for Phase 1 dose escalation clinical trial of 186RNL in LM with patient accrual planned for Q4 2021 AUSTIN, Texas, Aug. 19, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today presented data from a preclinical study evaluating its lead investigational drug, Rhenium-186 Nanoliposome (186RNL), in the treatment of leptomeningeal metastases (LM), and presented plans for a Phase 1 clinical trial of 186RNL also in LM. The data and upcoming trial plans were presented...

Avance Gas: Key information relating to the dividend for the second quarter 2021

Written by Customer Service on August 19, 2021. Posted in Public Companies.

Key information relating to the dividend to be paid by Avance Gas Holding ltd. for the second quarter 2021: Dividend amount: $0.02 Declared currency: USD Last day including right: 30 August 2021 Ex-date: 31 August 2021 Record date: 1 September 2021 Payment date: 16 September 2021 Date of approval: 18 August 2021 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

On the offer to purchase AS “Olainfarm” shares – announcement by AS “AB CITY”

Written by Customer Service on August 19, 2021. Posted in Public Companies.

With the following AS “Olainfarm” informs that on August 19, 2021 it has received announcement from AS “Olainfarm” shareholder AS “AB CITY” on offer to purchase AS “Olainfarm” shares. Full announcement in English attached.AttachmentABCity_19.08.2021_en

Lands’ End Announces Second Quarter Fiscal 2021 Earnings Conference Call

Written by Customer Service on August 19, 2021. Posted in Public Companies.

DODGEVILLE, Wis., Aug. 19, 2021 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Thursday, September 2, 2021, to discuss its second quarter fiscal 2021 financial results. A news release containing these results will be issued before the call. Listeners may access a live broadcast of the conference call on the Company’s investor relations website: http://investors.landsend.com/ in the Events and Presentations section or by dialing (866) 753-5836. An online archive of the broadcast will be available at approximately noon on September 2, 2021, and will be accessible on the Company’s website: http://investors.landsend.com/ in the Events and Presentations section. About Lands’ End, Inc. Lands’ End, Inc. (NASDAQ:LE) is a leading uni-channel retailer of casual...

BW Ideol 2021 First Half-Year Results

Written by Customer Service on August 19, 2021. Posted in Earnings Releases And Operating Results.

HIGHLIGHTSCreation of BW Ideol AS and listing on Euronext Growth Oslo as an offshore floating wind champion (March) Signed EolMed 30 MW pilot project engineering contract and license agreement (April) Signed partnership agreement with leading utility for South Brittany tender in France (April) Signed collaboration agreement with Hitachi ABB Power Grids on developing industry-first floating substation solution (June) Signed Joint Development Agreement with Eneos Corporation for a commercial scale floating wind farm in Japan (July) Submitted applications for ScotWind tender with joint venture partners for a total of 2.1 GW (July) Signed design and engineering Services contract with undisclosed leading party for a commercial scale floating wind farm in Taiwan (July) Signed Heads of Terms with an undisclosed party for a commercial scale...

REE Automotive Awarded $17 USD Million Funding from the UK Government

Written by Customer Service on August 19, 2021. Posted in Public Companies.

Funding will allow REE to advance commercial production of its breakthrough REEcorner™ technology and ultra-modular EV platforms Project to help accelerate industry shift towards net zero-emissions with REE’s technology designed to support extensive range of electric vehiclesTEL AVIV, Israel, Aug. 19, 2021 (GLOBE NEWSWIRE) — REE Automotive Ltd. (NASDAQ: “REE”), an innovator in e-mobility which recently started to trade on Nasdaq, today announced that its REEcorner™ technology was awarded $17 million USD funding from the UK government as part of a $57 USD million investment, coordinated through the Advanced Propulsion Centre (APC). The investment is in line with the UK government’s ambition to accelerate the shift to zero-emission vehicles and de-carbonize the UK’s transport networks. The award funding follows an intensive vetting...

LSI Industries Reports Fourth Quarter and Full-Year Fiscal 2021 Results and Declares Quarterly Cash Dividend

Written by Customer Service on August 19, 2021. Posted in Earnings Releases And Operating Results.

CINCINNATI, Aug. 19, 2021 (GLOBE NEWSWIRE) — LSI Industries Inc. (NASDAQ: LYTS, or the “Company”), a leading U.S. based manufacturer of commercial lighting and display solutions, today announced results for the fourth quarter and full-year fiscal 2021. FOURTH QUARTER 2021 SUMMARYNet Sales increased 53% versus Prior Year, organic sales increased 39% Completed acquisition of JSI Store Fixtures on May 21, 2021 Net Income of $0.2 million; Adjusted Net Income of $3.3 million Diluted EPS of $0.01, including $0.08 of acquisition related expense Adjusted EPS $0.12 versus $0.07 prior yearFISCAL YEAR 2021 SUMMARYNet Sales increased 3% from prior year to $316 million Net Income of $5.9 million; Adjusted Net Income of $9.8 million Diluted EPS of $0.21; Adjusted EPS of $0.36 versus $0.15 prior year EBITDA of $16.1 million; Adjusted EBITDA...

Formula Systems Reports Second Quarter 2021 Financial Results: Record-Breaking Results with Double Digit Growth Across All Key Financial Indices

Written by Customer Service on August 19, 2021. Posted in Earnings Releases And Operating Results.

OR YEHUDA, Israel, Aug. 19, 2021 (GLOBE NEWSWIRE) — Formula Systems (1985) Ltd. (NASDAQ: FORTY), a global information technology holding company engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, today announced its results for the second quarter and six months-period ended June 30, 2021. Financial Highlights for the Second Quarter Ended June 30, 2021Consolidated revenues for the second quarter ended June 30, 2021 increased by 34.5% to a record breaking $587.9 million compared to $437.1 million in the same period last year. Consolidated operating income for the second quarter ended June 30, 2021 increased by 24.1% to a record breaking $50.5 million, with growth recorded across Formula’s entire investment...

Month: August 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals